Robert C. Green

64.6k total citations · 3 hit papers
342 papers, 16.7k citations indexed

About

Robert C. Green is a scholar working on Genetics, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Robert C. Green has authored 342 papers receiving a total of 16.7k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Genetics, 63 papers in Psychiatry and Mental health and 58 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Robert C. Green's work include BRCA gene mutations in cancer (105 papers), Genomics and Rare Diseases (91 papers) and Dementia and Cognitive Impairment Research (56 papers). Robert C. Green is often cited by papers focused on BRCA gene mutations in cancer (105 papers), Genomics and Rare Diseases (91 papers) and Dementia and Cognitive Impairment Research (56 papers). Robert C. Green collaborates with scholars based in United States, Canada and United Kingdom. Robert C. Green's co-authors include Amy L. McGuire, J. Scott Roberts, Andrew J. Saykin, Heidi L. Rehm, Michael W. Weiner, Clifford R. Jack, Arthur W. Toga, John Q. Trojanowski, Leslie M. Shaw and William J. Jagust and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Robert C. Green

331 papers receiving 16.3k citations

Hit Papers

ACMG recommendations for reporting of incidental findings... 2013 2026 2017 2021 2013 2013 2018 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert C. Green United States 62 5.8k 4.3k 3.9k 2.9k 2.4k 342 16.7k
Teri A. Manolio United States 86 6.1k 1.0× 3.4k 0.8× 2.1k 0.5× 5.7k 2.0× 2.8k 1.2× 215 37.6k
Cathie Sudlow United Kingdom 60 3.5k 0.6× 2.6k 0.6× 1.7k 0.4× 2.6k 0.9× 2.2k 0.9× 217 20.9k
Lindsay A. Farrer United States 71 4.4k 0.8× 7.2k 1.7× 4.3k 1.1× 7.4k 2.6× 1.3k 0.6× 425 23.6k
Rudi G. J. Westendorp Netherlands 92 1.7k 0.3× 6.2k 1.4× 3.4k 0.9× 4.0k 1.4× 1.8k 0.8× 577 30.7k
Alan B. Zonderman United States 85 1.8k 0.3× 4.5k 1.0× 4.5k 1.2× 3.1k 1.1× 3.0k 1.3× 450 27.0k
Walter A. Rocca United States 99 3.4k 0.6× 6.9k 1.6× 10.2k 2.6× 3.2k 1.1× 2.6k 1.1× 347 33.2k
Albert Hofman Netherlands 91 2.5k 0.4× 4.0k 0.9× 2.1k 0.5× 4.6k 1.6× 2.6k 1.1× 360 31.4k
Naomi E. Allen United Kingdom 50 5.8k 1.0× 3.8k 0.9× 1.1k 0.3× 3.7k 1.3× 4.2k 1.8× 134 23.0k
Cornelia M. van Duijn Netherlands 96 7.1k 1.2× 9.6k 2.2× 4.7k 1.2× 11.8k 4.1× 3.3k 1.4× 676 40.3k
M. Arfan Ikram Netherlands 96 1.4k 0.2× 6.4k 1.5× 6.5k 1.7× 3.5k 1.2× 3.4k 1.4× 837 34.1k

Countries citing papers authored by Robert C. Green

Since Specialization
Citations

This map shows the geographic impact of Robert C. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Green more than expected).

Fields of papers citing papers by Robert C. Green

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Green. The network helps show where Robert C. Green may publish in the future.

Co-authorship network of co-authors of Robert C. Green

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Green. A scholar is included among the top collaborators of Robert C. Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Green. Robert C. Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gold, Nina B., et al.. (2025). O35: A genotype-first approach among adults at risk for treatable monogenic disorders reveals underdiagnosis and incomplete penetrance. Genetics in Medicine Open. 3. 102111–102111. 1 indexed citations
2.
Nathan, Aparna, Stuart R. Lipsitz, Satoshi Koyama, et al.. (2025). Nonadherence to guidelines for genetic testing in families with ovarian cancer shows racial bias. Genetics in Medicine. 27(7). 101444–101444. 1 indexed citations
3.
Uveges, Melissa Kurtz, Hadley Stevens Smith, Stacey Pereira, et al.. (2024). Family genetic risk communication and reverse cascade testing in the BabySeq project. Genetics in Medicine. 27(3). 101350–101350.
4.
Fieg, Elizabeth L., Natasha Y. Frank, Robert C. Green, et al.. (2024). Processes and outcomes from a clinical genetics e-consultation service managed by a primary care physician champion. SHILAP Revista de lepidopterología. 2. 101831–101831.
5.
Green, Robert C., et al.. (2024). Genetic counselors’ perspectives on genomic screening of apparently healthy newborns in the United States. SHILAP Revista de lepidopterología. 2. 101885–101885. 1 indexed citations
6.
Gold, Jessica I., Sarina Madhavan, Joseph Park, et al.. (2023). Phenotypes of undiagnosed adults with actionable OTC and GLA variants. Human Genetics and Genomics Advances. 4(4). 100226–100226. 2 indexed citations
7.
Zawatsky, Carrie L. Blout, et al.. (2023). Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty. Pharmacogenomics. 24(10). 539–549. 11 indexed citations
8.
Lewis, Anna, Emma Perez, Anya E. R. Prince, et al.. (2022). Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization. Genome Medicine. 14(1). 114–114. 32 indexed citations
9.
Kaur, Hundeep, Roman P. Jakob, Jan K. Marzinek, et al.. (2021). The antibiotic darobactin mimics a β-strand to inhibit outer membrane insertase. Nature. 593(7857). 125–129. 155 indexed citations
10.
Rehm, Heidi L., et al.. (2021). Primary care providers’ responses to unsolicited Lynch syndrome secondary findings of varying clinical significance. Genetics in Medicine. 23(10). 1977–1983. 5 indexed citations
11.
Lewis, Anna, Bartha Maria Knoppers, & Robert C. Green. (2021). An international policy on returning genomic research results. Genome Medicine. 13(1). 115–115. 21 indexed citations
12.
Schwartz, Talia S., Kurt D. Christensen, Melissa Kurtz Uveges, et al.. (2021). Effects of participation in a U.S. trial of newborn genomic sequencing on parents at risk for depression. Journal of Genetic Counseling. 31(1). 218–229. 7 indexed citations
13.
Lane, William J., Nicholas Gleadall, Sunitha Vege, et al.. (2020). Multiple GYPB gene deletions associated with the U− phenotype in those of African ancestry. Transfusion. 60(6). 1294–1307. 10 indexed citations
14.
Lane, William J., Sunitha Vege, Helen Mah, et al.. (2019). Automated typing of red blood cell and platelet antigens from whole exome sequences. Transfusion. 59(10). 3253–3263. 29 indexed citations
15.
Ziniel, Sonja I., Sarah Savage, Kurt D. Christensen, et al.. (2018). Enhancing Autonomy in Biobank Decisions: Too Much of a Good Thing?. Journal of Empirical Research on Human Research Ethics. 13(2). 125–138. 5 indexed citations
16.
Guan, Yue, Debra Roter, Lori H. Erby, et al.. (2018). Communication Predictors of Patient and Companion Satisfaction with Alzheimer’s Genetic Risk Disclosure. Journal of Health Communication. 23(8). 807–814. 8 indexed citations
17.
Christensen, Kurt D., Sarah Savage, Noelle Huntington, et al.. (2016). Family health history reporting is sensitive to small changes in wording. Genetics in Medicine. 18(12). 1308–1311. 6 indexed citations
18.
Christensen, Kurt D., Dmitry Dukhovny, Uwe Siebert, & Robert C. Green. (2015). Assessing the Costs and Cost-Effectiveness of Genomic Sequencing. Journal of Personalized Medicine. 5(4). 470–486. 77 indexed citations
19.
Peterson, David B., Chris Corcoran, Carlos Cruchaga, et al.. (2013). Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study. Alzheimer s & Dementia. 10(3). 366–371. 28 indexed citations
20.
Fanshawe, Thomas, A Toby Prevost, J. Scott Roberts, et al.. (2008). Explaining Behavior Change after Genetic Testing: The Problem of Collinearity between Test Results and Risk Estimates. Genetic Testing. 12(3). 381–386. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026